UCSF University of California, San Francisco      About UCSF       Search UCSF       UCSF Medical Center     
About Us
History of IWHRC
Research Projects
Contact Us

Janice Y. Tsoh, Ph.D



(415) 502-8438 (voice)

Box 0984 , LPPI TRC 104
University of California, San Francisco
San Francisco, CA. 94143 - 0984

  • State University of New York, Binghamton, NY, B.A., 1990, Psychology
  • University of Rhode Island, Kingston, RI, M.A., 1993, Clinical Psychology
  • University Univ. of Mississippi/Veterans Affairs, Residency, 1994-95, Clinical Psychology
  • University of Rhode Island, Kingston, RI, Ph.D., 1995, Clinical Psychology
  • University of Texas M.D. Anderson Cancer, Post-doc, 1995-97, Cancer Prevention
  • University of California San Francisco, CA., Post-doc, 1997-99, Substance Abuse
  • University of California San Francisco, CA, Certificate, 2001-02, Clinical Research
Positions and Honors
Positions and Employment
1999-2000 Assistant Research Psychologist, Psychiatry, University of California San Francisco, CA
2000-present Assistant Adjunct Professor, Psychiatry, University of California San Francisco, CA
2001-present Attending Medical Staff, Langley Porter Psychiatric Institute, Department of Psychiatry, University of California San Francisco, CA
Professional Licensure
1998 – present Licensed Clinical Psychologist, State of California (PSY 15878)
Honors and Awards
1996 University Cancer Foundation Fellowship Award in Cancer Prevention Research,  University of Texas M.D. Anderson Cancer Center, Houston, TX

New Investigator Award –Tobacco Related Disease Research Program, University of California

2000 Mentored Patient Oriented Research Career Development Award – National Institute on Drug Abuse
2005 Nominated for the First Annual Award for Outstanding Faculty Mentorship to Postdoctoral Scholars, Postdoctoral Scholars Association, University of California San Francisco
Selected peer-reviewed publications (in chronological order)
  • Guilmette TJ, Tsoh JY, & Malcolm C (1995).  Orientation & three-word recall in predicting memory: Age effects and false-negative errors.  Neuropsychiatry, Neuropsychology, & Behavioral Neurology, 8, 20-25.
  • Johnson WG, Tsoh JY, & Varnado PJ (1996).  Eating disorders: Efficacy of pharmacological and psychological interventions.  Clinical Psychology Review, 16, 457-478.
  • Prokhorov AV, Emmons KM, Pallonen UE, & Tsoh JY (1996).  Respiratory response to cigarette smoking among young smokers: A pilot study.  Preventive Medicine, 25, 633-640.
  • Skaar KL, Tsoh JY, Cinciripini PM, Wetter D, Prokhorov AV, & Gritz ER (1996).  Current approaches in smoking cessation.  Current Opinion in Oncology, 8, 434-440.
  • Skaar KL, Tsoh JY, McClure JB, Wetter D, Cinciripini PM, & Gritz ER (1997).  Smoking Cessation 1: An overview of research.  Behavioral Medicine, 23, 5-12.
  • Tsoh JY, McClure JB, Skaar KL, Wetter D, Cinciripini PM, Prokhorov AV, Friedman K & Gritz ER (1997).  Smoking Cessation 2: Components of effective interventions.  Behavioral Medicine, 23, 15-27.
  • McClure JB, Skaar KL, Tsoh JY, Wetter D, Cinciripini PM, & Gritz ER (1997).  Smoking Cessation 3: Needed health care policy changes.  Behavioral Medicine, 23, 29-34.
  • Pallonen UE, Velicer WF, Prochaska JO, Rossi JS, Bellis JM, Tsoh JY, Migneault JP, Smith NF, & Prokhorov AV (1998).  Computer-based smoking cessation interventions in adolescents: Description, feasibility, and six-month follow-up findings.  Substance Use & Misuse, 33, 935-965.
  • Cinciripini PM, Gritz ER, Tsoh JY, & Skaar KL (1998).  Smoking cessation and cancer prevention. In J. C.
  • Holland (Ed.), Psycho-oncology (pp. 27-44). New York: Oxford University Press.
  • Ruggiero L, Tsoh JY, Everett K, Guise B, & Fava JL (2000).  The Transtheoretical Model of Change: Comparison of smoking in pregnant and nonpregnant women.  Addictive Behaviors, 25, 239-251
  • Tsoh JY, Humfleet GL, Munoz R, Reus V, Hartz D, & Hall SM (2000).  Development of depression following smoking cessation treatment.  American Journal of Psychiatry, 157, 368-374.
  • Prochaska JO, Velicer WF, Fava JL, Rossi JS & Tsoh JY (2001).  A stage-matched expert system intervention for a total population of smokers. Addictive Behaviors, 261, 583-602.
  • Hall SM, Delucchi K, Velicer W, Kahler C, Ranger-Moore M, Hedeker D, Tsoh JY, Niaura R (2001).  Statistical analysis of randomized trials in smoking treatment. Nicotine and Tobacco Research, 3, 193-202.
  • Benowitz NL, Jacob P 3rd, Ahijevych K, Jarvis MJ, Hall S, LeHouezec J, Hansson A, Lichtenstein E, Henningfield J, Tsoh J, Hurt RD, Velicer W. (2002) Biochemical Verification of Tobacco Use and Cessation.  Nicotine Tobacco  Research, 4, 149-159.
  • Kohn CS, Tsoh JY & Weisner CM (2003). Smoking Status Among Substance Abusers:  Baseline Characteristics and Association with Treatment Outcomes at 12-Months. Drug and Alcohol Dependence, 69, 61-71.
  • Tsoh JY, Lam JN, Delucchi K, & Hall SM (2003).  Smoking and Depression in Chinese Americans. American Journal of Medical Sciences, 326, 187-191.
  • Cinciripini PM, Wetter DW, Tomlinson GE, Tsoh JY, De Moor CA, Cinciripini LG, Baile W.S., & Minna JD (2004). The effects of the DRD2 polymorphism on smoking cessation and negative affect: Evidence for a pharmacogenetic effect on mood.  Nicotine and Tobacco Research, 6, 229-239.
  • Tsoh JY & Hall SM (2004).  Depression and Smoking cessation: The Transtheoretical Model Perspective. Addictive Behaviors, 29, 801-805.
  • Prochaska JJ, Rossi JS, Redding CA, Rosen AB, Tsoh JY, Humfleet GL, Eisendrath SJ, Meisner MR & Hall SM (2004). Depressed smokers and stage of change: Implications for treatment interventions. Drug and Alcohol Dependence, 76, 143- 151.
  • Haug NA, Hall SM, Prochaska JJ, Rosen AB, Tsoh JY, Humfleet GL Delucchi K, Rossi JS, Redding CA, & Eisendrath S (2005) Acceptance of nicotine dependence treatment among currently depressed smokers.  Nicotine and Tobacco Research, 7, 217-224.
  • Cinciripini PM, Tsoh JY, Wetter DW, Lam C, De Moor C, Cinciripini L, Skaar K, Friedman K, Baile W, Anderson C, & Minna JD (2005). Combined effects of venlafaxine, nicotine replacement and brief counseling on smoking cessation.  Experimental and Clinical Pharmacology, 13, 282-92.
  • Schmitt E, Tsoh JY, Dowling G, & Hall SM (2005).  Smoking Cessation in Older Clients in a Case Management Program. Journal of Aging and Health, 17, 717-733.
  • Hall SM, Tsoh JY, Prochaska J, Eisendrath S, Rossi JS, Redding CA, Rose AB, Meisner M, Humfleet G, & Gorecki J (in press).  Treatment of Depressed Psychiatric Outpatients for Cigarette Smoking. American Journal of Public Health.
  • Sun A, Zhang J, Tsoh JY, Wong-Kim E, & Chow E (in press). The effectiveness in utilizing chinese media to promote breast health among chinese women. Journal of Health Communications.
  • Fuller, B.E., Guydish, J., Tsoh, J., Reid, M., Resnick, M., Zammarelli, L., Ziedonis, D.M., Sears, C., & McCarty, D. (in press) Attitudes Toward the Integration of Smoking Cessation Programs in Drug Abuse Treatment Clinics.  Journal of Substance Abuse Treatment.
Research Support
Current Research Support
1/1/2003 - 12/31/2006

TURSG-03-102-01-PBP (PI: Tsoh)
American Cancer Society

The study develops and tests the efficacy of a family assisted intervention, a self-help education intervention designed for the family or friends of smokers (supporters) to be more effective in assisting their loved ones to quit smoking. A family-assisted intervention in the form of a self-help booklet based on the Transtheoretical Model of Change (TTM) will aim at teaching the supporters how to use the stages of change framework to apply different strategies that best match with smokers’ readiness to quit smoking.
Role: PI

9/01/1999 - 8/31/2009

P50 DA09253 (PI: Hall; Co-Directors Sorensen and Havassy)
NIH/National Institute on Drug Abuse

Treatments for Complex Patients in New Settings (Treatment Research Center)
This multidisciplinary Center is unified around the theme of behavioral treatments of complex drug abusing patients in new settings.  Dr. Tsoh leads a developmental study on A Stepped-Care Intervention for Current and Former Smokers in Chemical Dependency Treatment.
Role: Co-investigator

7/01/2005 – 06/30/2008 14RT-0160 (PI: Tsoh)
Tobacco Related Disease Research Program

Stage-Based Scheduled Smoking Intervention for Chinese
The purpose of this study is to examine the efficacy of a proposed intervention that will apply the best empirically validated technologies for smoking reduction and smoking cessation to Chinese American smokers at various levels of readiness for quitting smoking.
Role: PI

9/15/2005 – 9/14/2010 R25 MH074500 (PI: Areán)

Community-Academic Research Training Alliance (CARTA)
CARTA focuses on training the next generation of academic and community investigators in psychosocial interventions research with underserved populations.  The main goal is to train investigators from academia and the community in how to build research partnerships around clinical interventions research.
Role: Co-investigator, Faculty Mentor.

Completed in the last 3 years
8/16/2000 - 7/31/2005 K23 DA00468-03 (PI: Tsoh)
NIH/National Institute on Drug Abuse

Treating Chinese Smokers with Interactive Expert Systems

This mentored patient-oriented research award support Dr. Tsoh's career development in the area of nicotine dependence and tobacco control, particularly targeting smoking cessation efforts to the ethnic minority populations.  This study transferred the interactive expert system technology in smoking cessation to Chinese-American smokers and tested the efficacy of the intervention using a randomized clinical trial in this population.
Role: PI

9/30/2001 – 8/31/2005 R01HL069363 (PI: Wong)
NIH/National Heart Lung and Blood Institute

Chinese Community Smoking Cessation Project
The goal of the study was to test the efficacy of a culturally and linguistically tailored physician directed, nurse managed, smoking cessation and relapse prevention intervention among hospitalized Chinese smokers.
Role: Co-investigator

9/30/02 – 9/29/2007 U10 DA015815-01 (PI: Sorensen)
NIH/National Institute on Drug Abuse

California-Arizona Clinical Trials Network Node
The University of California, San Francisco (UCSF) proposes a cooperative agreement to lead a node in the National Institute on Drug Abuse Treatment Clinical Trials Network (CTN). The overall goal of the Research Node is to participate in and conduct high-quality multi-site clinical trials of interventions for drug abuse and addiction and to guide the development, dissemination, and adoption of effective interventions in the field. Dr. Tsoh served as a Co-Investigator participating in research protocol development.
Role: Co-investigator

7/01/2002 – 12/31/2003 11BT-1900 (Hall, PI of UCSF Subcontract; Dowling PI of prime award)
Tobacco Related Disease Research Program

Partnership to Promote Smoking Cessation in Older Adults
This project developed survey instruments and conducted interviews concerning methods to promote smoking cessation in older adults. Dr. Tsoh served as Co-PI of the UCSF Subcontract, responsible for conducting focus groups, interviews, and data analyses.
Role: Co-investigator

12/1/2001 - 12/31/2003 PI: Tsoh
UC Tobacco-Related Disease Research Program

Recruitment of Chinese Smokers for a Smoking Cessation Trial.
The purpose of this study was to examine the use of two recruitment approaches: media advertising and targeted mailing to outreach Chinese smokers for a smoking cessation clinical trial (project funded by K23 DA00468).
Role: PI

7/1/1999 – 3/31/2003 8KT-0012 (PI: Tsoh)
UC Tobacco-Related Disease Research Program

Smoking and Depression in Chinese vs. Non-Chinese
The study examined relationship between depression and stages of change and other smoking characteristics among Chinese and non-Chinese smokers. 
Role: PI

Updated: May 1, 2007